Prostate cancers rank as the third most common cancer among men. Between 2012 and 2016, there was an increase in incidence rates compared to 2007-2011, particularly after the age of 55. The highest incidence occurs in the 70-74 age group.
Prostate cancer originates when prostate cancer cells in the prostate gland begin to grow uncontrollably. The prostate, a gland exclusive to males, produces some of the fluid that constitutes semen.
Prostate cancer results from alterations in the DNA of normal prostate cells.
Researchers have found several risk factors for prostate cancer, but how these factors increase risk is still unclear. These include:
Age: Prostate cancer risk increases with age, especially in men over 50.
Ethnicity: Prostate cancer is more common in men of African ancestry than in Asian men.
Family History: Having a close male relative diagnosed with prostate cancer before 60 increases your risk, and having a female relative with breast cancer might also raise your susceptibility to prostate cancer.
Obesity: Recent studies indicate a possible connection between obesity and prostate cancer.
Diet: Prostate cancer research is examining the link between diet and prostate cancer, with some evidence indicating that a high calcium diet might increase the risk.
Prostate cancer often goes unnoticed until it grows large enough to affect urination. Symptoms of prostate cancer may include:
Frequent urination, often during the night.
Urgency to use the restroom.
Difficulty to start peeing.
Straining or prolonged duration while urinating.
Weak flow.
A sensation of incomplete bladder emptying.
Blood in urine or semen.
However, these symptoms can also result from benign prostate enlargement.
Signs of cancer spreading (advanced prostate cancer or metastatic prostate cancer) include bone and back pain, appetite loss, testicular pain, and unexplained weight loss.
Prostate cancer can be detected early through prostate-specific antigen (PSA) blood tests and digital rectal exams (DRE). Abnormal results from these tests often lead to further testing, like a prostate biopsy, to confirm the presence of cancer.
Prostate cancer treatment options vary based on individual circumstances. These include:
Observation or Active Surveillance
Surgery
Brachytherapy, External Beam Radiation Therapy (EBRT), and Other Radiation Therapy
Cryotherapy, HIFU, and Other Ablative Treatments
Hormone Therapy
Chemotherapy
Immunotherapy
Targeted Drug Therapy
Bone-related Treatments
After diagnosis, an oncology doctor will discuss these options, weighing their benefits against potential risks and side effects.
While prostate cancer can't be entirely prevented due to uncontrollable risk factors like age, race, and family history, certain actions may help reduce the risk of prostate cancer.
Maintain a healthy weight.
Stay physically active.
Follow a balanced diet rich in fruits, vegetables, and whole grains while limiting red and processed meats, sugary drinks, and highly processed foods.
Consider moderating calcium intake, but follow medical advice for those undergoing prostate cancer treatment.
Benign prostatic hyperplasia (BPH) or benign prostate enlargement (BPE) is a common condition in men over 50, affecting urination. It is not cancerous and typically not a serious health threat.
An enlarged prostate does not increase the risk of developing prostate cancer; the risk is the same for men with or without an enlarged prostate.
.webp?sfvrsn=ce3832a8_1)
Regular check-ups are crucial for early detection and successful treatment of prostate cancer. Men over 50, or at higher risk, should discuss screenings with our healthcare provider.
Prince Court Medical Centre offers exceptional cancer care with advanced technology and compassionate service. Our dedicated oncologists provide personalised diagnostic and treatment services, focussing on both the disease and patient well-being.
Schedule a consultation today for proactive prostate health management.
Be the first in line to receive the latest updates and promotions, delivered directly to your inbox.
Please enter a valid email
Thank you for subscribing!
Please verify that you are not a robot.
